Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

DNA ploidy analysis as an adjunct for the detection of relapse in B-lineage acute lymphoblastic leukemia.

Kenney B, Zieske A, Rinder H, Smith B.

Leuk Lymphoma. 2008 Jan;49(1):42-8. doi: 10.1080/10428190701760052.

PMID:
18203010
2.

[Comparison of the immunophenotype of patients with B lineage acute lymphoblastic leukemia at diagnosis and relapse].

Liu YR, Chang Y, Fu JY, Cheng YF, Zhang LP, Li LD, Wang H, Liu GL, Chen SS, Huang XJ, Lu DP.

Zhonghua Xue Ye Xue Za Zhi. 2006 May;27(5):335-8. Chinese.

PMID:
16875586
3.

[Clinical significance for minimal residual disease detection by 4 color flow cytometry in adult and childhood B lineage acute lymphoblastic leukemia].

Liu YR, Zhang LP, Chang Y, Cheng YF, Fu JY, Li LD, Wang H, Liu GL, Chen SS, Huang XJ, Lu DP.

Zhonghua Xue Ye Xue Za Zhi. 2006 May;27(5):302-5. Chinese.

PMID:
16875577
4.

Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia.

Karawajew L, Dworzak M, Ratei R, Rhein P, Gaipa G, Buldini B, Basso G, Hrusak O, Ludwig WD, Henze G, Seeger K, von Stackelberg A, Mejstrikova E, Eckert C.

Haematologica. 2015 Jul;100(7):935-44. doi: 10.3324/haematol.2014.116707. Epub 2015 May 22.

5.

A novel and easy FxCycle™ violet based flow cytometric method for simultaneous assessment of DNA ploidy and six-color immunophenotyping.

Tembhare P, Badrinath Y, Ghogale S, Patkar N, Dhole N, Dalavi P, Kunder N, Kumar A, Gujral S, Subramanian PG.

Cytometry A. 2016 Mar;89(3):281-91. doi: 10.1002/cyto.a.22803. Epub 2015 Dec 15.

6.

Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.

DiGiuseppe JA, Fuller SG, Borowitz MJ.

Cytometry B Clin Cytom. 2009 Mar;76(2):150-5. doi: 10.1002/cyto.b.20440.

8.

[Flow cytometric detection of minimal residual disease in pre-cursor-B-acute lymphoblastic leukemia on the basis of phenotypic aberrancies on minor leukemic cell populations].

Wu M, Sun XF, Xu ZM, Zhang XY, Li FR, Wang XG, Chen XL, Lin HQ, Wen HG, Sun X, Song TW.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Aug;13(4):557-62. Chinese.

PMID:
16129033
9.

[Detection of minimal residual disease in B lineage acute lymphoblastic leukemia by 4-color flow cytometry].

Liu YR, Wang H, Chang Y, Cheng YF, Fu JY, Zhang LP, Liu GL, Chen SS.

Zhonghua Xue Ye Xue Za Zhi. 2005 Jun;26(6):327-31. Chinese.

PMID:
16185473
10.

Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.

van Wering ER, Beishuizen A, Roeffen ET, van der Linden-Schrever BE, Verhoeven MA, Hählen K, Hooijkaas H, van Dongen JJ.

Leukemia. 1995 Sep;9(9):1523-33.

PMID:
7658722
11.

[The clinical significance of detecting minimal residual disease in acute childhood B-cell lymphoblastic leukemia with flow cytometry].

Zhang LP, Cheng YF, Liu GL, Lu AD, Liu YR, Wang H.

Zhonghua Er Ke Za Zhi. 2005 Jul;43(7):481-5. Chinese.

PMID:
16083543
12.

Immunophenotypic Modulation of the Blast Cells in Childhood Acute Lymphoblastic Leukemia Minimal Residual Disease Detection.

Burnusuzov HA, Spasova MI, Murdjeva MA, Stoyanova AA, Mumdziev IN, Kaleva VI, Belcheva MI, Bosheva MN.

Folia Med (Plovdiv). 2016 Mar 1;58(1):28-35. doi: 10.1515/folmed-2016-0004.

PMID:
27383875
13.

Identification of residual leukemic cells by flow cytometry in childhood B-cell precursor acute lymphoblastic leukemia: verification of leukemic state by flow-sorting and molecular/cytogenetic methods.

Øbro NF, Ryder LP, Madsen HO, Andersen MK, Lausen B, Hasle H, Schmiegelow K, Marquart HV.

Haematologica. 2012 Jan;97(1):137-41. doi: 10.3324/haematol.2011.051383. Epub 2011 Sep 20.

14.

Detection of residual disease in pediatric B-cell precursor acute lymphoblastic leukemia by comparative phenotype mapping: a study of five cases controlled by genetic methods.

Dworzak MN, Stolz F, Fröschl G, Printz D, Henn T, Fischer S, Fleischer C, Haas OA, Fritsch G, Gadner H, Panzer-Grümayer ER.

Exp Hematol. 1999 Apr;27(4):673-81.

PMID:
10210325
15.
16.

Peripheral blood flow cytometry for the diagnosis of pediatric acute leukemia: Highly reliable with rare exceptions.

Cheng J, Klairmont MM, Choi JK.

Pediatr Blood Cancer. 2019 Jan;66(1):e27453. doi: 10.1002/pbc.27453. Epub 2018 Sep 25.

PMID:
30255571
17.

Stability of leukemia-associated immunophenotypes in precursor B-lymphoblastic leukemia/lymphoma: a single institution experience.

Chen W, Karandikar NJ, McKenna RW, Kroft SH.

Am J Clin Pathol. 2007 Jan;127(1):39-46.

PMID:
17145625
18.

Significance of CD34/CD123 expression in detection of minimal residual disease in B-ACUTE lymphoblastic leukemia in children.

Zeidan MA, Kamal HM, El Shabrawy DA, Esh AM, Sattar RH.

Blood Cells Mol Dis. 2016 Jul;59:113-8. doi: 10.1016/j.bcmd.2016.05.005. Epub 2016 May 9.

PMID:
27282579
19.

Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia.

Ciudad J, San Miguel JF, López-Berges MC, Vidriales B, Valverde B, Ocqueteau M, Mateos G, Caballero MD, Hernández J, Moro MJ, Mateos MV, Orfao A.

J Clin Oncol. 1998 Dec;16(12):3774-81.

PMID:
9850021
20.

Flow cytometric characterization of phenotype, DNA indices and p53 gene expression in 55 cases of acute leukemia.

Powari M, Varma N, Varma S, Marwaha RK, Sandhu H, Ganguly NK.

Anal Quant Cytol Histol. 2002 Jun;24(3):159-65.

PMID:
12102128

Supplemental Content

Support Center